Amphastar Pharmaceuticals AMPH
NASDAQ AMPH
$26.14 +0.20 (+0.77%)
As of: Oct 21, 2026 · 2:39 PM EDT

Amphastar Pharmaceuticals (AMPH) Long-Term Debt Repayments (2013 - 2026)

Updated

Amphastar Pharmaceuticals' Long-Term Debt Repayments was $47,000 in Q2 2026, up 27.0% from $37,000 a year earlier and up 62.1% from the prior quarter.

Analysis

Amphastar Pharmaceuticals (AMPH) Long-Term Debt Repayments (2013 - 2026) Analysis & Trends

On a trailing twelve-month basis, Amphastar Pharmaceuticals' Long-Term Debt Repayments was $224,000 through Jun 30, 2026, down 3.0% year-over-year; for FY2025, it was $223,000, down 97.3% from FY2024.

  • Long-Term Debt Repayments shows a five-year compound annual growth rate of -51.6% (FY2020 to FY2025).
  • In earlier years, Long-Term Debt Repayments was $8.26 million in FY2024 (-97.4%), $318.66 million in FY2023, $1.78 million in FY2022 (-95.2%) and $36.74 million in FY2021 (+337.3%).
  • Quarterly Long-Term Debt Repayments has moved between $29,000 (Q1 2026) and $200.07 million (Q3 2023) over five years.
  • Compared with a year earlier, Long-Term Debt Repayments was higher in two of the last eight quarters, with an average decline of 44.9%.
  • The best year-over-year quarter for Long-Term Debt Repayments over five years was Q1 2023 (growth of 79.9%); the worst was Q3 2024 (a decline of 100.0%).
  • Per Business Quant data, AMPH's Long-Term Debt Repayments in the three quarters before Q2 2026 was $29,000 (Q1 2026), $104,000 (Q4 2025) and $44,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,136.90 Bn 1,105.48 Bn 19.71 Bn 873.00 Mn
2 Johnson & Johnson 617.06 Bn 535.59 Bn 17.26 Bn 1.00 Mn
3 AbbVie 501.38 Bn 474.49 Bn 12.70 Bn 2.00 Bn
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn 5.00 Mn
5 Novartis Ag 297.92 Bn 261.91 Bn 11.24 Bn 20.00 Mn
6 Astrazeneca 261.31 Bn 235.00 Bn 12.86 Bn 2.46 Bn
7 Amgen 236.29 Bn 191.69 Bn 7.24 Bn -
8 Gilead Sciences 190.40 Bn 164.60 Bn 6.22 Bn 17.00 Mn
9 Pfizer 169.55 Bn 116.19 Bn 10.94 Bn -
10 Amphastar Pharmaceuticals 1.14 Bn -459,050.01 93.47 Mn 47,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 47,000.00
Mar 31, 2026 29,000.00
Dec 31, 2025 104,000.00
Sep 30, 2025 44,000.00
Jun 30, 2025 37,000.00
Mar 31, 2025 38,000.00
Dec 31, 2024 115,000.00
Sep 30, 2024 41,000.00
Jun 30, 2024 8.01 Mn
Mar 31, 2024 98,000.00
Dec 31, 2023 50.15 Mn
Sep 30, 2023 200.07 Mn
Jun 30, 2023 67.46 Mn
Mar 31, 2023 968,000.00
Dec 31, 2022 128,000.00
Sep 30, 2022 522,000.00
Jun 30, 2022 593,000.00
Mar 31, 2022 538,000.00
Dec 31, 2021 613,000.00
Sep 30, 2021 28.86 Mn
API Access

Amphastar Pharmaceuticals Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=AMPH&period=max&api_key=YOUR_API_KEY